Cargando…
Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber's Hereditary Optic Neuropathy
The eye is at the forefront of the application of gene therapy techniques to medicine. In the United States, a gene therapy treatment for Leber's congenital amaurosis, a rare inherited retinal disease, recently became the first gene therapy to be approved by the FDA for the treatment of disease...
Autores principales: | Ratican, Sara E., Osborne, Andrew, Martin, Keith R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954906/ https://www.ncbi.nlm.nih.gov/pubmed/29853847 http://dx.doi.org/10.1155/2018/7108948 |
Ejemplares similares
-
The pattern of retinal ganglion cell dysfunction in Leber hereditary optic neuropathy
por: Majander, A., et al.
Publicado: (2017) -
The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy
por: Zhang, Yong, et al.
Publicado: (2018) -
XIAP Protects Retinal Ganglion Cells in the Mutant ND4 Mouse Model of Leber Hereditary Optic Neuropathy
por: Wassmer, Sarah J., et al.
Publicado: (2020) -
Propagation and Selectivity of Axonal Loss in Leber Hereditary Optic Neuropathy
por: Coussa, Razek Georges, et al.
Publicado: (2019) -
Establishing risk of vision loss in Leber hereditary optic neuropathy
por: Lopez Sanchez, M. Isabel G., et al.
Publicado: (2021)